Shire plc to Reorg, Set to Axe 180 UK R&D Jobs
Shire is cutting jobs but others are hiring! Check it out! (Isn't it tempting?)
Pharmaceuticals company Shire is cutting up to 180 British research and development jobs as it scales back drug development programmes beyond its focus on rare diseases. The cutbacks will affect Shire's main British office in Basingstoke, southern England, where it employs 520 people, a Shire spokesman said on Thursday. Chief Executive Flemming Ornskov is streamlining the company's R&D pipeline around its most promising prospects in rare diseases, where drugs can command prices in the hundreds of dollars for a year's treatment.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)
Pharmaceuticals company Shire is cutting up to 180 British research and development jobs as it scales back drug development programmes beyond its focus on rare diseases. The cutbacks will affect Shire's main British office in Basingstoke, southern England, where it employs 520 people, a Shire spokesman said on Thursday. Chief Executive Flemming Ornskov is streamlining the company's R&D pipeline around its most promising prospects in rare diseases, where drugs can command prices in the hundreds of dollars for a year's treatment.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)